Massmutual Trust Co. FSB ADV Purchases 634 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Massmutual Trust Co. FSB ADV boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 309.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 839 shares of the medical device company’s stock after acquiring an additional 634 shares during the period. Massmutual Trust Co. FSB ADV’s holdings in Cooper Companies were worth $85,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Kestra Advisory Services LLC raised its position in Cooper Companies by 10.0% in the 3rd quarter. Kestra Advisory Services LLC now owns 1,291 shares of the medical device company’s stock worth $411,000 after purchasing an additional 117 shares during the last quarter. Rafferty Asset Management LLC raised its position in Cooper Companies by 7.5% in the 3rd quarter. Rafferty Asset Management LLC now owns 5,170 shares of the medical device company’s stock worth $1,644,000 after purchasing an additional 361 shares during the last quarter. Envestnet Asset Management Inc. raised its position in Cooper Companies by 35.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 138,764 shares of the medical device company’s stock worth $44,128,000 after purchasing an additional 36,574 shares during the last quarter. Hsbc Holdings PLC raised its position in Cooper Companies by 5.5% in the 3rd quarter. Hsbc Holdings PLC now owns 56,484 shares of the medical device company’s stock worth $17,976,000 after purchasing an additional 2,923 shares during the last quarter. Finally, Dark Forest Capital Management LP bought a new stake in shares of Cooper Companies during the 3rd quarter valued at $367,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.2 %

Shares of COO opened at $91.51 on Friday. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $104.07. The firm’s 50 day moving average is $92.95 and its 200-day moving average is $94.61. The stock has a market capitalization of $18.22 billion, a PE ratio of 53.75, a P/E/G ratio of 2.27 and a beta of 1.02. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.83 by $0.02. The company had revenue of $942.60 million for the quarter, compared to analysts’ expectations of $948.07 million. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm earned $0.77 earnings per share. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Analysts Set New Price Targets

COO has been the subject of several recent research reports. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and upped their target price for the company from $100.00 to $120.00 in a research report on Wednesday, March 13th. Citigroup upped their price objective on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Mizuho upped their target price on shares of Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $110.00 target price (up from $105.00) on shares of Cooper Companies in a research note on Friday, March 1st. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $111.42.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.